World's Best Scientists 2026 revealed!

D-Index & Metrics

Best Female Scientists

D-Index
107
Citations
40060
World Ranking
1026
National Ranking
621

Medicine

D-Index
109
Citations
42329
World Ranking
5801
National Ranking
3114

Research.com Recognitions

  • 2011 - Fellow of the American Statistical Association (ASA)

Overview

Susan G. Hilsenbeck is affiliated with Baylor College of Medicine in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with notable contributions in Oncology, Molecular Biology, Cancer Research, Genetics, and Pulmonary and Respiratory Medicine.

The scientist's scholarly output includes significant work on cancer biology, especially focused on breast and cervical cancer. Their main topics of study include:

  • Cancer Genomics and Diagnostics
  • Cancer-related Molecular Pathways
  • Cancer Research and Treatments
  • Advanced Breast Cancer Therapies
  • Cancer Cells and Metastasis
  • Cervical Cancer and HPV Research
  • Breast Cancer Treatment Studies

Frequent coauthors collaborating with Hilsenbeck include:

  • Mothaffar F. Rimawi
  • Shaun Bulsara
  • Matthew J. Ellis
  • Lacey E. Dobrolecki
  • Bing Zhang

Hilsenbeck's research has been published extensively in several journals, with frequent publication venues as follows:

  • Cancer Research
  • Journal of Clinical Oncology
  • Clinical Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • UNC Libraries

Some of the recent papers authored or co-authored by Hilsenbeck include:

  • Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment, 2021, Nature Communications
  • Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis, 2022, Nature Cancer
  • Neurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in Breast Cancer, 2020, Cancer Cell
  • Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer, 2021, Clinical Cancer Research
  • LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study, 2024, The Lancet Oncology

The scientist was awarded the distinction of Fellow of the American Statistical Association (ASA) in 2011.

Best Publications

  • Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy

    Xiaoxian Li;Michael T. Lewis;Jian Huang;Carolina Gutierrez

  • Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

    Chad J. Creighton;Xiaoxian Li;Melissa Landis;J. Michael Dixon

  • Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer

    Matthew D. Burstein;Anna Tsimelzon;Graham M. Poage;Kyle R. Covington

  • Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer

    Jenny C. Chang;Eric C. Wooten;Anna Tsimelzon;Susan G. Hilsenbeck

  • Role of the Estrogen Receptor Coactivator AIB1 (SRC-3) and HER-2/neu in Tamoxifen Resistance in Breast Cancer

    C. Kent Osborne;Valerie Bardou;Torsten A. Hopp;Gary C. Chamness

  • Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes

    Robert M. Lavinsky;Kristen Jepsen;Thorsten Heinzel;Joseph Torchia

  • BRCAPRO Validation, Sensitivity of Genetic Testing of BRCA1/BRCA2, and Prevalence of Other Breast Cancer Susceptibility Genes

    Donald A. Berry;Edwin S. Iversen;Daniel F. Gudbjartsson;Elaine H. Hiller

  • Medical Complications and Outcomes After Hip Fracture Repair

    Valerie A. Lawrence;Susan G. Hilsenbeck;Helaine Noveck;Roy M. Poses;Roy M. Poses

  • p53 Is Mutated in a Subset of Advanced-Stage Prostate Cancers

    R Bookstein;D MacGrogan;S G Hilsenbeck;F Sharkey

  • A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models

    Xiaomei Zhang;Sofie Claerhout;Aleix Prat;Lacey E. Dobrolecki

  • Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.

    M. L. Rothenberg;J. R. Eckardt;J. G. Kuhn;H. A. Burris

  • A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.

    Jessica D. Kessler;Kristopher T. Kahle;Kristopher T. Kahle;Tingting Sun;Kristen L. Meerbrey

  • Comparison of the Effects of a Pure Steroidal antiestrogen With Those of Tamoxifen in a Model of Human Breast Cancer

    Osborne Ck;Coronado-Heinsohn Eb;Hilsenbeck Sg;McCue Bl

  • Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors.

    D. Williams Parsons;Angshumoy Roy;Yaping Yang;Tao Wang

  • Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8

    Zachary C. Hartman;Graham M. Poage;Petra den Hollander;Anna Tsimelzon

  • Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.

    A. V. Lee;J. G. Jackson;J. L. Gooch;S. G. Hilsenbeck

  • Incidence and hospital stay for cardiac and pulmonary complications after abdominal surgery.

    Valerie A. Lawrence;Susan G. Hilsenbeck;Cynthia D. Mulrow;Rahul Dhanda

  • Identification of Tumor-initiating Cells in a p53 Null Mouse Model of Breast Cancer

    Mei Zhang;Fariba Behbod;Rachel L. Atkinson;Melissa D. Landis

  • Risk of Pulmonary Complications After Elective Abdominal Surgery

    Valerie A. Lawrence;Rahul Dhanda;Susan G. Hilsenbeck;Carey P. Page

  • Phase I and pharmacokinetic trial of weekly CPT-11

    M L Rothenberg;J G Kuhn;H A Burris;J Nelson

Frequent Co-Authors

C. Kent Osborne
C. Kent Osborne Baylor College of Medicine
Rachel Schiff
Rachel Schiff Baylor College of Medicine
Chad J. Creighton
Chad J. Creighton Baylor College of Medicine
Jenny C. Chang
Jenny C. Chang Houston Methodist
Suzanne A. W. Fuqua
Suzanne A. W. Fuqua Baylor College of Medicine
Michael T. Lewis
Michael T. Lewis Baylor College of Medicine
Chad A. Shaw
Chad A. Shaw Baylor College of Medicine
Jeffrey M. Rosen
Jeffrey M. Rosen Baylor College of Medicine
Gordon B. Mills
Gordon B. Mills Oregon Health & Science University
David A. Wheeler
David A. Wheeler Baylor College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine can take many forms beyond the traditional MD pathway. Pursuing online nursing programs is a flexible option, especially for those balancing work or family responsibilities. For those seeking a cost-effective route, affordable nursing programs online are increasingly popular, making a nursing degree more accessible than ever.

If you’re already an RN, advancing your education could further your career. Looking for ways to save on tuition? Consider the lower rn to bsn online cost options to efficiently earn your Bachelor of Science in Nursing. For aspiring nurse leaders and educators, online nursing phd programs provide the expertise needed to excel in advanced roles.

Not a nurse but interested in entering the field? There are accelerated options like online direct entry msn programs designed for non-nurses, which can help you fast-track your nursing career. These pathways offer diverse opportunities for growth and specialization in the healthcare sector.

Best Scientists Citing Susan G. Hilsenbeck

Trending Scientists